The long-term use of oral bisphosphonate osteoporosis drugs such as Actonel, Boniva, and Fosamax may be associated with a doubling in esophageal cancer risk, but the risk to individual users remains small, researchers say.
from: http://www.webmd.com/osteoporosis/news/20100902/osteoporosis-drugs-may-be-linked-to-cancer-risk?src=RSS_PUBLIC
Related posts:
- Low Risk of Jaw Problems With Oral Osteoporosis Drugs
Osteoporosis drugs and serious jaw problems have been linked in past studies, but new... - High-Fiber Diet Linked to Lower Colon Cancer Risk
Eating a high-fiber diet is linked with a reduced risk of colorectal cancer, according... - FDA: Prostate Cancer Risk From BPH, Hair Drugs
The prostate drugs Proscar, Avodart, and Jalyn and the hair-loss drug Propecia add to... - Tall Women Linked to Greater Cancer Risk
Taller women are at greater risk for many types of cancers compared with their... - Study: Stomach Acid Drugs Linked to Fracture Risk
Long-term, regular users of a proton pump inhibitor (PPI) such as Nexium, Prevacid, Prilosec,...
